Search
for
Sort by
Research 331–360 of 1000+
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies
- Finasteride for the Treatment of Hidradenitis Suppurativa in Children and Adolescents
- Serum biotin levels in women complaining of hair loss
- Green tea in dermatology.
- Skin Pigmentation Types, Causes and Treatment—A Review
- Role of FGFR2-signaling in the pathogenesis of acne
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Comment on the Use of Biotin for Hair Loss
- Beyond the usual: a case of acrodermatitis enteropathica clinically resembling erythrokeratoderma variabilis
- Issue Information
- Clinical pearls in dermatology 2018
- Nanoporous Silica Entrapped Lipid-Drug Complexes for the Solubilization and Absorption Enhancement of Poorly Soluble Drugs
- Improvement in Hair Loss and Better Hair Quality with Vitamin Therapy in Monilethrix
- Recent advances in the treatment of psoriasis
- Pediatric Dermatology Photoquiz: A 14-Year-Old Boy with Abrupt-Onset Hair Changes
- Sorafenib-Associated Facial Acneiform Eruption
- Frontal Fibrosing Alopecia in Men: A Review of the Literature
- Treatment options for polycystic ovary syndrome
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Frontal Fibrosing Alopecia: A Review
- Congenital milia En plaque on scalp
- Acne-Associated Syndromes
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- SnapshotDx Quiz: January 2021
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Hyperandrogenic Disorders
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆